You are here: Industry Insights > COVID-19

News List

US FDA amends J&J vaccine fact sheet to include rare bleeding risk ExpressPharma
January 14, 2022
The amendment fact sheet follows similar moves for the vaccine by other regulators, including that of the European Medicines Agency (EMA) in October.
Healthcare Fraud Prevention Partnership Releases White Paper on COVID-19-Related Fraud, Waste, and Abuse prnewswire
January 14, 2022
Balancing the delivery of necessary healthcare services with the needed fraud, waste, and abuse controls is vital for the healthcare system to be resilient to the impact of the COVID-19 pandemic, as well as future national emergencies.
iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants prnewswire
January 14, 2022
Recent expansion of supplier capabilities will support commercial and government customers in their fight against COVID-19.
New Vaxzevria data further support its use as third dose booster WorldPharmaNews
January 14, 2022
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that Vaxzevria (ChAdOx1-S [Recombinant]), when given as a third dose booster...
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement contractpharma
January 14, 2022
Emergent BioSolutions Inc. announced that Fuad El-Hibri, founder and executive chairman, has decided to retire effective April 1, 2022.
CDC Advises N95s as Best Masks Against Coronavirus drugs.com
January 14, 2022
In a departure from its prior advice on face masks, new guidance from the Centers for Disease Control...
Skipping COVID Vaccine in Pregnancy Brings Big Risks to Mothers, Babies drugs.com
January 14, 2022
Unvaccinated pregnant women are putting themselves and their baby at risk for serious complications of COVID-19, according to new research out of Scotland.
Oral COVID-19 antivirals market set for growth CPhIonline
January 13, 2022
Lagevrio and Paxlovid are the only COVID-19 pills cleared for emergency use at present, but others are coming with developers racing to bring oral antivirals to this potentially lucrative market.
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19 WorldPharmaNews
January 13, 2022
Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo to treat COVID-19...
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study ExpressPharma
January 13, 2022
responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19 vaccine or with placebo.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page